Lowering Dosage of Retinopathy Injection Treatment Did Not Decrease Effectiveness Intravitreous bevacizumab has become an increasingly common way to treat retinopathy of prematurity (ROP) in infants, but systemic toxicity remains one of its potentially dangerous side effects.
Read Featured ResearchResearch and Training Details | |
---|---|
Faculty | 14 |
Joint Appointment Faculty | 1 |
Research Fellows and Post Docs | 9 |
Research Graduate Students | 2 |
Total Annual Grant Award Dollars | $1,038,537 |
Clinical Activities and Training | |
---|---|
Staff Physicians | 1 |
Clinical Fellows | 1 |
Inpatient Encounters | 2,040 |
Outpatient Encounters | 32,294 |